• Agfa-Gevaert’s Q3 2026 adjusted EBITDA fell 64% year over year to €1 million.
• Sales totaled €210 million, while annualized savings reached €64 million by quarter-end.
• Imaging & Advanced Materials swung to an adjusted EBITDA loss of €1.4 million on lower volumes, silver-related timing effects and mix.
• HealthCare IT’s 12-month order intake rose 21% year over year to €197 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agfa Gevaert NV published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.